发明授权
- 专利标题： Cloning and expression of .beta.APP-C100 receptor (C100-R)
- 专利标题（中）： βAPP-C100受体（C100-R）的克隆和表达
-
申请号： US559397申请日： 1995-11-15
-
公开(公告)号： US6083713A公开(公告)日： 2000-07-04
- 发明人: Susan P. Manly , Michael R. Kozlowski , Rachael L. Neve
- 申请人： Susan P. Manly , Michael R. Kozlowski , Rachael L. Neve
- 申请人地址： NY New York MA Belmont
- 专利权人： Bristol-Myers Squibb Company,McLean Hospital Corporation
- 当前专利权人： Bristol-Myers Squibb Company,McLean Hospital Corporation
- 当前专利权人地址： NY New York MA Belmont
- 主分类号： G01N33/53
- IPC分类号： G01N33/53 ; A61K31/00 ; A61K31/70 ; A61K31/7088 ; A61K38/00 ; A61K39/395 ; A61P25/28 ; C07K14/47 ; C07K14/705 ; C07K16/28 ; C07K19/00 ; C12N1/21 ; C12N5/10 ; C12N15/00 ; C12N15/09 ; C12N15/113 ; C12N15/12 ; C12P21/02 ; C12P21/08 ; C12Q1/68 ; C12R1/91 ; G01N33/566 ; G01N33/577 ; G01N33/68 ; C12N15/70 ; C12N15/85
摘要：
The present invention relates to the cloning of .beta.APP-C100 receptor (C100-R), and genetically engineered host cells which express the C100-R. Such engineered cells may be used to evaluate and screen drugs and analogs of .beta.-APP involved in Alzheimer's Disease.
公开/授权文献
信息查询
IPC分类:
